MAXCYTE INC's ticker is and the CUSIP is 57777K106. A total of 120 filers reported holding MAXCYTE INC in Q3 2023. The put-call ratio across all filers is 10.33 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,373 | -71.5% | 3,004 | -58.0% | 0.00% | -100.0% |
| Q2 2023 | $32,850 | +93757.1% | 7,157 | +0.7% | 0.00% | 0.0% |
| Q1 2023 | $35 | +118.8% | 7,108 | +139.8% | 0.00% | 0.0% |
| Q4 2022 | $16 | -100.0% | 2,964 | -85.7% | 0.00% | -50.0% |
| Q3 2022 | $134,000 | +458.3% | 20,676 | +305.2% | 0.00% | +100.0% |
| Q2 2022 | $24,000 | +166.7% | 5,103 | +260.9% | 0.00% | – |
| Q1 2022 | $9,000 | -72.7% | 1,414 | -57.1% | 0.00% | -100.0% |
| Q4 2021 | $33,000 | -67.0% | 3,298 | -59.9% | 0.00% | -66.7% |
| Q3 2021 | $100,000 | – | 8,216 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NORTH RUN CAPITAL, LP | 480,900 | $3,361,000 | 4.94% |
| Casdin Capital, LLC | 13,971,334 | $97,660,000 | 4.38% |
| Vitruvian Partners LLP | 4,385,670 | $30,656,000 | 3.25% |
| RIVER GLOBAL INVESTORS LLP | 2,100,000 | $14,849,000 | 1.95% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $1,258,000 | 1.52% |
| Pier Capital, LLC | 1,017,753 | $7,114,000 | 0.91% |
| First Light Asset Management, LLC | 1,321,406 | $9,237,000 | 0.82% |
| Montanaro Asset Management Ltd | 929,000 | $6,557,000 | 0.81% |
| Nicholas Investment Partners, LP | 776,963 | $5,431,000 | 0.39% |
| Bleichroeder LP | 250,000 | $1,764,000 | 0.31% |